Blood tests for diagnosing fatty liver disease and its effects
Part of Digestive system clinical trials.
This study looks at whether simple blood tests can help diagnose nonalcoholic fatty liver disease and predict its complications. If you have NAFLD, participating may help doctors find less invasive ways to monitor your liver health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have nonalcoholic fatty liver disease (NAFLD), a condition where fat builds up in the liver not caused by alcohol.
- You must not have viral hepatitis (such as hepatitis B or C).
- You must not drink more than 3 drinks a day (men) or more than 2 drinks a day (women).
- You must not be taking certain medicines that can cause fat in the liver, such as tamoxifen, amiodarone, estrogen, or corticosteroids.
- You must not have cancer or another severe organ disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tracks how liver scarring (fibrosis) and fat buildup (steatosis) change over time in people with nonalcoholic fatty liver disease (NAFLD). It helps doctors understand risk factors so they can better predict and manage the disease.
This study looks at integrated diagnostic tests to find early liver problems sooner. It may help you (if referred to the community liver clinic) get more timely information about what’s going on.
This study is looking for new ways to detect liver scarring (fibrosis) in people with fatty liver disease (NAFLD, NASH, MASLD, or MASH). If you qualify, you will give a blood sample to help identify biomarkers that could replace biopsies.
This study looks at what drives non-alcoholic fatty liver disease and how it affects the body, including immune-related changes. You may be invited if you have confirmed fatty liver disease or, alternatively, if you are a healthy person with no liver disease.
This study builds a research registry (and optional test results follow-up) for adults who either need a routine liver biopsy or may have fatty liver risk based on body weight and other health history. It helps researchers learn more about non-alcoholic fatty liver disease (fatty liver not caused by alcohol) and how it may progress.
This study looks at whether simple blood tests can help predict liver scarring (fibrosis) in people with fatty liver disease. If you join, you'll have a quick, non-invasive scan of your liver to check for fat and scarring.
Hear when a new Non-alcoholic Fatty Liver Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.